ArticleCancers2026

CABOPRE: Evaluating Perioperative Cabozantinib's Efficacy and Biomarkers for Cytoreductive Nephrectomy in Advanced Renal Cell Carcinoma.

Guillermo de Velasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.